Condition: Indeterminate Pulmonary Nodules · Lung Metastases · Second Primary Cancer · Sponsor: Royal Marsden NHS Foundation Trust
This study will assess the utility of radiomics and artificial intelligence approaches to new lung nodules in patients who have undergone radical treatment for a previous cancer.
This description comes directly from the study's public registry record.
Sejal Jain · 020 7808 2603 · sejal.jain@rmh.nhs.uk
Laura Boddy · 020 7808 2603 · laura.boddy@rmh.nhs.uk
Always discuss trial participation with your own doctor first.
| The Royal Marsden NHS Foundation Trust (Chelsea Site) | London, United Kingdom | Recruiting |
| Royal Brompton Hospital | London, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05375591